Rats and mice are relatively resistant to severe anaphylactic shock and to large doses of histamine given parenterally. Furthermore, methods effective for producing severe active cutaneous hypersensitivity in many species are ineffective for producing skin hypersensitivity in the rat. Rats and mice treated with Hemophilus pertussis vaccine show increased susceptibility to the deathproducing effects of parenterally administered histamine, serotonin, and to anaphylacfic shock (1, 2).
A commercial Hcmophilus pertussis vaccine prepared for human immunization was compared with a standard Hemophilus pertussis vaccine, l The supernatant fluid of the commercial vaccine produced an acute inflammation in normal rat skin; the supernatant fluid of the standard vaccine did not have this activity. Washed commercial vaccine and a National Institutes of Health standard vaccine, washed or tmwashed, produced similar cutaneous reactions in rat skin when the vaccines contained equal numbers of organisms. In all experiments commercial vaccine, washed 3 times and suspended in sterile normal saline, was used. Concentrations of the vaccine were determined turbidimetrically in an electrophotometer. Washed vaccine resuspended in saline to contain the same number of organisms as the original vaccine, which was about 6 X 10 l° organisms per ml., is referred to as whole pertussis vaccine.
Whole pertussis vaccine diluted to contain about 1.2 X 10 l° organisms per ml. is referred to as pertussis vaccine 1:5. Typhoid vaccine prepared for human immunizations * was also washed and resuspended in saline to contain the same number of organisms as whole pertussis vaccine and pertussis vaccine 1:5.
0.2 ml. of whole pertussis vaccine injected subcutaneously in equally divided doses in a fore and hind paw produces severe inflammation in the injected paws in about 5 days. This inflammation is referred to as the primary hypersensitive response. If the uninjected fore and hind paws of a rat which has developed a primary hypersensitive response are challenged with 0.2 ml. of pertussis vaccine 1:5, severe inflammation develops in the challenged paws within 24 hours. This reaction is referred to as the secondary hypersensitive response. The first injection of whole vaccine is ~ considered as sensitizing the rat.
The primary and secondary hypersensitive responses can be elicited in abdominal skin though the reactions are not as severe in the gross as in paw skin. For some experiments sensitizing injections of vaccine were made in abdominal skin but the secondary hypersensitive response was alsways elicited in paw skin because injection sites could be precisely located and equivalent areas of skin could be removed readily for quantitation of edema.
In some experiments, rats were sensitized by injection of vaccine in the dorsa of the right fore and hind paws. In these experiments the left paws were used to test the subsequent response of the rat to an agent such as pertussis vaccine, typhoid vaccine, or some other substance. In other experiments rats were sensitized by injection of vaccine in shaved abdominal skin. In these experiments each rat could be used to test the response to 2 agents; one was tested in the right paws and the other agent was tested in the left paws.
To measure the severity of the inflammatory reaction in the secondary hypersensitive response, tissue water was determined in paw skin 24 hours after challenge. The full thickness dorsal paw skins, from the wrist or ankle to the interdigital spaces, were carefully removed from exsanguinated rats. The fore and hind paw skins from one side were combined for a determination. Each sample, fore and hind paw skin, was weighed, dried at 72°C. for 4 days and reweighed; the percentage water in the sample was calculated. In the figures and tabular matter percentages of water in paw skins have been rounded to the nearest whole number.
The edema-producing agents: serotonin, histamine, and 48/80, 8 and the control injections of saline were also tested in paws on one side of a rat; 0.2 ml. of the agent tested was injected in equally divided doses in a fore and hind paw. Concentrations of histamine and serotonin are recorded as micrograms of free base per milliliter while concentrations of 48/80 are re-corded as micrograms of dry material per milliliter. Dilutions of these agents were made in sterile saline. The method for measuring the edema was the same as that for the vaccine except that the paw skins were obtained 2 hours after injection (3).
The rats were bled for agglutinin titers from tail veins. The sera were stored at --30°C.; all titrations were done at the completion of the experiment. Serial double dilutions of a serum were made in saline. Then an equal volume of washed pertussis or typhoid vaccine, diluted to contain about 9 X 109 organisms per ml., was added to each serum dilution. The tubes were incubated at room temperature for 2 hours and then centrifuged for 4 minutes at 2,500 R.p.u. The sediment in each tube was individually resuspended. The agglutinin titer was taken as the highest serum dilution in which gross aggregations of bacterial particles had occurred. For averaging titers the arithmetic mean of the logarithms of titers was computed and this figure was converted into titer units.
Lymph node cells were prepared for passive transfer tests from popliteal and axillary lymph nodes of rats whose paws had been injected with pertussis vaccine. Sterile cold Tyrode's solution and sterile instruments and utensils were used for these procedures. The preparation of cell suspensions was carried out at about 6°C. Rats were killed by a blow on the head. The nodes, carefully dissected from areolar tissue, were pooled in Tyrode's solution and finely minced with sharp scissors. The supernatant was filtered through coarse gauze. The sediment with added Tyrode's was gently ground by hand with a mortar and pestle; the superuatant was similarly filtered and added to the initial supernatant suspension. The pooled supernatant suspension of cells was centrifuged for 3 minutes at 1500 a.P.~. The packed cells were resuspended in-an appropriate volume of Tyrode's solution to give the desired number of cells per milliliter of suspension.
EXPEI~ IMI~.NTAL OBSERVATIONS
Preliminary Experiments.--After the initial demonstration of cutaneous hypersensitivity in the rat skin, various experiments were designed to compare the doses and routes of administration of the vaccine, and to measure the severity of the secondary hypersensitive response in rats challenged at various intervals after sensitization. In each experiment 4 or more rats were used to test each variable. 0.2 ml. of whole pertussis vaccine was selected as the sensitizing dose because higher doses did not appear to produce greater sensitivity. Lower doses might have been used; a primary hypersensitive response was observed in occasional rats injected with 0.2 ml. of pertussis vaccine 1:5 and these rats challenged with pertussis vaccine 1:5 showed a strong secondary hypersensitive response.
A secondary hypersensitive response was eficited in sensitized rats with dilutions of vaccine higher than 1:5 but this dilution was selected because it was the lowest dilution of vaccine which regularly produced little gross inflammation at 24 hours in the normal rat but maximal inflammation in sensitized rats.
The secondary hypersensitive response was distinctly more severe in rats that had been sensitized subcutaneously than in rats sensitized intravenously; this was true regardless of the dose of vaccine used for the sensitization or the time interval between sensitization and challenge.
The secondary hypersensitive response produced by pertussis vaccine 1:5 was measured in rats challenged at various time intervals after subcutaneous sensitization with 0.2 ml. of whole pertussis vaccine. No hypersensitive response occurred in paws challenged 1 day after the sensitizing injection. Two of 4 rats challenged at 3 days showed a slight response. All rats showed severe secondary hypersensitive responses at 5, 7, 10, 14, and 28 days after sensitizing injections. The secondary hypersensitive response appeared to be most severe at 10 and 14 days; at these times the hypersensitive inflammation reached peak intensity 12 to 24 hours after challenge.
On the basis of these findings we elected to challenge rats 12 days after the sensitizing injection of vaccine and to measure the secondary hypersensitive response 24 hours after challenge.
Some Gross and Microscopic Observations on the Morphology of the Primary and Secondary Hypersensitive
Response.--0.2 ml. of whole pertussis vaccine injected subcutaneously in equally divided doses in a fore and hind paw of a normal rat produced local edema which subsided slowly over a period of 2 to 3 days. Four or 5, occasionally 3 or 6 days after the injection, the injected paws became swollen, red, and warm, Fig. 1 ; the rat limped and guarded the inflamed paws. This inflammation of the primary response developed quite rapidly reaching peak intensity over a period of 12 to 24 hours. Subcutaneous hemorrhage, necrosis, and sloughing of the dorsal skin occurred occasionally. The inflammation was severe for 4 to 6 days, and it subsided slowly so that by 15 to 20 days only a firm subcutaneous nodule, 1 to 3 ram. in diameter, remained. Histologic sections of paw skin 5 days after the injection of whole vaccine showed dilatation of vessels, severe edema, and intense infiltration of the dermis and subcutaneous areolar tissue by leukocytes including lymphocytes, plasma cells, and a few polymorphonuclear leukocytes, Fig. 3 . A small central abscess consisting of cellular debris surrounded by polymorphonuclear leukocytes was seen in some sections. Paw skin taken at the time of the peak inflammation contained 8 to 12 per cent more water than normal paw skins. 0.2 ml. of pertussis vaccine 1:5 injected subcutaneously in equally divided doses in a fore and hind paw of a normal rat produced a minimal acute edema which became inconspicuous in the gross at 24 hours. Histologic sections of skin 24 hours after injection of vaccine of this concentration showed a slight edema and an infiltrate of mononuclear leukocytes, Fig. 4 . When a rat sensitized 12 days previously with whole vaccine was challenged with pertussis vaccine 1:5, severe inflammation developed in the challenged paws within 24 hours. The inflammation was as severe in the gross as that of the primary response at 5 to 6 days. Histologic sections taken 24 hours after challenge showed marked dilatation of vessels and severe edema, Fig. 5 ; the edematous subcutaneous tissues contained many leukocytes, though these cells were less numerous than in the primary response. Paw skins showing a severe secondary hypersensitive response contained 7 to 10 per cent more water than paw skin of normal rats injected 24 hours previously with pertussis vaccine 1:5. Paw skins injected with pertussis vaccine can be compared with normal paw skin, Fig. 2 .
Sensitization of Rats to Pertussis Vaccine and to Typhoid Vaccine Using
Pertu3sis Vaccine as an "Adjuvant".--Pertussis vaccine has been shown to act as an "adjuvant" in sensitizing rats to anaphylactic shock (4). It seemed reasonable to find out whether pertussis vaccine mixed with another antigen would produce cutaneous hypersensitivity to a second antigen. For this experiment a particulate antigen, typhoid vaccine, was used.
Forty-eight rats were divided into 4 groups of 12. The right paws of rats in group I were injected with 0.2 ml. of whole pertussis vaccine. The right paws of rats in group II were injected with 0.2 ml. of whole typhoid vaccine. Rats in group III received no injections. In group IV 6 rats were injected in the right paws with 0.4 ml. of a mixture of equal parts of whole pertussis vaccine and whole typhoid vaccine; the remaining 6 rats received 0.2 mi. of whole pertussis vaccine in the right paws and 0.2 ml. of whole typhoid vaccine in the left paws. Twelve days later, 6 rats in each of groups I, II, and III were challenged in the left paws with pertussis vaccine 1:5; the other 6 rats in each of these groups were challenged in the left paws with typhoid vaccine 1:5. All rats in the fourth group were challenged in the left paws with typhoid vaccine 1 : 5. The rats were sacrificed 24 hours after challenge and the paw skins were removed for water determinations.
The results, presented in Text- fig. 1 , show the water determinations for each rat plotted as a dot; the solid bar represents the mean for similarly treated animals. Pertussis vaccine 1:5 produced severe inflammation in rats sensitized with whole pertussis vaccine but not in rats injected with whole typhoid vaccine. Neither pertussis nor typhoid vaccine 1:5 produced inflammation in rats previously injected with typhoid vaccine. Typhoid vaccine 1:5 produced severe inflammation in rats sensitized with a mixture of whole pertussis and typhoid vaccine but not in rats which received the two vaccines in opposite paws. In the following experiment this "adjuvant" activity of pertussis vaccine was tested using soluble antigens.
Sensitization of Rats to Human and Rabbit Gamma Globulin.--A preliminary
experiment demonstrated that sterile human serum produced a severe inflammation in the paws of rats sensitized with a mixture of pertussis vaccine and human serum but not in rats injected with human serum alone. The following experiment was designed to give some information about the specificity of the reaction using more homogeneous soluble antigens.
Human gamma globulin, 120 mg./ml., was mixed with an equal volume of whole pertussis vaccine. Each of 6 rats was injected subcutaneously in the abdominal skin with 0.8 ml. of the mixture given in 4 equal depots. A second group of 6 rats was treated similarly except that each rat received rabbit gamma globulin and pertussis vaccine in the same volume and concentration as the first group. Thus, each rat received a total of 0.4 ml. of whole pertussis vaccine (twice the usual dose) and 48 mg. of either human or rabbit gamma globulin. Twelve days later the right paws of all rats were each challenged with 0.1 ml. of a solution containing 60 mg./ml, of human gamma globulin and the left paws were challenged with a similar volume and concentration of rabbit gamma globulin. Paw skins were taken for water determinations 24 hours after challenge. (Paw skins of normal rats challenged with this volume and concentration of human or rabbit gamma globulin contain about 70 per cent water 24 hours after the injection.) 2 . Human gamma globulin produced severe inflammation in 4: of 6 rats sensitized with pertussis vaccine and human gamma globulin but it did not produce an appreciable response in rats sensitized to pertussis vaccine and rabbit gamma globulin. Similarly, rabbit gamma globulin produced severe inflammation in 4 of 6 rats sensitized to pertussis vaccine and rabbit gamma globulin but it did not produce a significant response in rats sensitized to pertussis vaccine and human gamma globulin. The "adjuvant" action of pertussis vaccine appeared to be similar for the particulate antigen, typhoid vaccine, and for these two soluble antigens. Furthermore, the sensitization appeared to be specific for the antigen added to the pertussis vaccine.
It is of interest that in other experiments using soluble antigens some of the rats injected with pertussis vaccine and antigen in separate depots developed cutaneous hypersensitivity to the soluble antigen. This is in contrast to our findings with the particulate antigen, typhoid vaccine, and could be explained by the fact that soluble antigen enters the circulation more readily than particulate antigen. Circulating soluble antigen may localize at the site of focal acute inflammation produced by whole pertussis vaccine in normal rats. By this means at least some soluble antigen may be "mixed" with pertussis vaccine. This same phenomenon may occur in anaphylactic sensitization in mice when pertussis vaccine and antigen are given by different routes (5) .
Agglutinin Response of the Rat to Pertussis and/or Typhoid Vaccine.--This
experiment was designed to study the circulating agglutinin response to pertussis vaccine and to see if pertussis vaccine, added to typhoid vaccine, affected the circulating agglutinin titers for typhoid vaccine.
Eighteen rats were divided into 3 groups of 6, and all animals were bled for baseline fiters.
The right paws of one group were injected with 0.2 ml. of whole pertussis vaccine, and second group with 0.2 ml. of whole typhoid vaccine, and the third group with 0.4 ml. of a mixture of equal parts of whole pertussis vaccine and whole typhoid vaccine. All rats were bled at 6, 10, 14, 22, and 28 days after the injections. The serum from each animal for each bleeding was titrated for agglutinins to typhoid and to pertussis vaccines. The results, plotted in Text- fig.  3 , are for the mean titers of each group of 6.
Rats injected with pertussis vaccine did not produce measurable agglutinins for typhoid vaccine; similarly rats injected with typhoid vaccine did not produce measurable agglutinins to pertussis vaccine. Rats injected with the mixture of vaccine did not respond with higher agglutinin titers to pertussis or typhoid than animals receiving pertussis or typhoid vaccine alone.
The antibody response to typhoid vaccine, with peak titers 6 to 24 days after immunization, is typical of the response of the rat to various bacterial and particulate red cell antigens given v/a different routes of administration (6) . The delayed antibody response to pertussis vaccine with peak titers 3 weeks after immunization is unusual; in this experiment differences in mean titers response. However, the failure of pertussis vaccine to affect the agglutinin response to typhoid vaccine in rats sensitized to the mixture of vaccines suggested that agglutinins to whole typhoid vaccine did not play a role in the hypersensitive response to typhoid vaccine. Passive transfer experiments were undertaken to study the role of serum antibody and of lymph node cells in the hypersensitive response.
Passive Transfer of Skin H~persensitivity to Pertussis Vaccine.--Passive trans-
fer of the cutaneous hypersensitive response was attempted in a series of experiments using serum flom hypersensitive donor rats.
Sera were obtained at various times from 6 to 28 days after sensitization. Some of the sera contained high and others low aggiutinin titers for pertussis vaccine. In some experiments the sera were injected into normal recipient rats in volumes from 1.0 to 6.0 ml. intravenously and/or intraperitoneally; in other experiments sera were injected into paw skin in volumes from 0.05 to 0.2 ml. per paw. Paws of recipient rats were challenged with pertussis vaccine variously 24 hours prior to, at the time of, or 24 hours after giving the serum. Passive transfer of skin hypersensitivity with serum was not observed in a single instance in any experiment.
In contrast to our findings with "immune" serum, we have passively transferred skin hypersensitivity by'using lymph node cells from sensitized rats. This passive transfer of hypersensitivity has been accomplished by several methods including the injection of lymph node cells intravenously, intraperitoneally, or into the skin which is challenged with vaccine. With the latter method, the cells can either be mixed with the vaccine, or given 24 hours prior to or 24 hours after challenge with the vaccine. Local passive transfer has given the most uniform results and is relatively economical of donor cells.
In one experiment twelve donor rats were prepared by injecting all four paws With whole pertussis vaccine, 0.2 ml. per paw. Fourteen days later each paw was again injected with 0.1 ml. of whole pertussis vaccine. Five days after the second injection the rats were sacrificed, and a lymph node cell suspension was prepared from pooled popliteal and axillary lymph nodes. Fifteen normal recipient rats were divided into groups I and II each containing 6 rats and group HI containing 3 rats. The right paws of all rats in group I and II were injected with 0.1 ml. of pertussis vaccine 1:5 and the left paws with 0.1 ml. of typhoid vaccine 1:5. The right and left paws of rats in group III were injected with saline. Twenty four hours later the right and left paws of rats in groups I and III were injected with 0.1 ml. of fresh lymph node cell suspension containing 5 X 108 eells/ml.; the right and left paws of rats in group II were injected with saline. Twenty four hours after injection of lymph node cells paw skins were obtained for water determinations. The results are presented in Text- fig. 4 . Paw skins injected with pertussis vaccine and lymph node cells were severely inflamed and contained about 80 per cent water; paw skins injected with lymph node cells and typhoid vaccine, lymph node cells alone, or vaccine alone showed little or no gross inflammation and contained about 70 per cent water. Apparently the hypersensitive response of the rat to pertnssis vaccine is similar to delayed or tuberculin type hypersensitivity studied extensively in other species, in that hypersensitivity can be transferred with cells but not with serum (7, 8) .
Cutaneous Reactivity of Pertussis Sensitized Rats to Histamine, Serotonin or 48/80.--In preliminary experiments we found that rats injected subcutaneously with 0.2 to 0.4 ml. of whole pertussis vaccine showed 6 to 14 days later increased susceptibility to death when challenged intravenously with large dosages of histamine. Possibly the cutaneous hypersensitivity to pertussis vaccine might be related to increased cutaneous reactivity to histamine and/or other agents which produce edema in rat skin. Accordingly, 21 rats were each injected in the abdominal skin with 0.4 ml. of whole pertussis vaccine given in four equal depots. A second group of 21 rats received no injections. Twelve days later 6 rats in each group were challenged intravenously with 75 rag. of histamine. Four of 6 sensitized rats died within 2 hours; none of the 6 normal controls died within 24 hours. The remaining 15 animals in each group were handled in the following manner: The right or left paws of 6 rats in each group were challenged with pertussis vaccine 1:5, and 22 hours later the right or left paws, not challenged with pertussis vaccine, were injected with histamine (100 #g./ml.), serotonin (0.5 #g./ml.), or saline. These doses of serotonin and histamine were selected because they produce an increase in tissue water of about 5 per cent. Doses of these agents twofold greater produce about a 10 per cent increase in tissue water but larger dosages do not produce more edema in paw skin which is sampled for water determinations. Therefore, under these conditions any slight increased reactivity produced by sensitization should be measurable. The response produced by each agent was measured 6 times in each group of rats; the response to pertnssis vaccine was measured 24 hours after challenge while the response to the other agents was measured 2 hours after challenge.
A summary of the results is presented in Table I . It is apparent that rats sensitized to pertussis vaccine do not show increased cutaneous reactivity to the edema-producing activity of histamine, serotonin, or 48/80. This is in sharp contrast to the increased susceptibility of sensitized rats to histamine given intravenously. This experiment did not exclude the possibility that tissue histamine and/or serotonin were important in the mediation of cutaneous hypersensitivity in rats sensitized to pertussis vaccine. The morphology of mast cell damage was studied in the following way.
The Role.of Histamine and~or Serotonin in the Mediation of Cutaneous
Paws of 18 sensitized and 18 non-sensitized rats were challenged with pertussis vaccine 1:5, 48/80 (5/~g./ml.), or saline. At 2, 6, and 24 hours after challenge, 6 sensitized and 6 non-sensitized rats were killed; thus, 4 paw skins challenged with pertussis, 48/80 or saline were obtained at each time interval. Paw skins were fixed in a mixture of ethanol 80 per cent and neutral formaldehyde 4 per cent; sections were stained with toluidine blue.
48/80 produced severe mast cell damage with extensive spillage of granules into the edematous areolar tissue. The damage was most apparent at 6 hours but still very evident 24 hours after injection of 48/80. Equivalent damage was produced by 48/80 in sensitized and non-sensitized rats. Pertussis vaccine 1:5 produced damage to only a few mast cells in and adjacent to vaccine pools; damage to mast cells was equivalent in sensitized and non-senitized rats. Pertussis vaccine produced only slightly greater damage to mast cells than saline.
Dibenamine inhibits the edema produced by serotonin; pyrilamine inhibits the edema produced by histamine, and the edema produced by agents which damage mast cells is inhibited by the treatment of rats with both drugs (3).
Twelve of 24 rats sensitized by the injection of whole pertussis vaccine in abdominal skin were injected with dibenamine (8 mg./kg.) and pyrilamine (16 mg./kg.); half of the dose of each drug was given intravenously and the other half intraperitoneally. Fifteen minutes after the drugs were given, the right paws of the treated and untreated rats were challenged with pertussis vaccine 1:5. At 4 hour intervals the treated rats were injected intraperitoneally with dibenamine (8 mg./kg.) and pyrilamine (16 mg./kg.). Four treated and 4 untreated rats were challenged in the left paws with 48/80 (1/~g./ml.) at 3, 11, and 23 hours.
These injections demonstrated that the dosages of drugs were sufficient to block the formation of edema by 48/80 during the 24 hour period. At 24 hours all paws challenged with pertussis vaccine showed severe inflammation; water determinations showed equivalent secondary hypersensitive responses for treated and untreated rats. In another experiment similar results were obtained using BOL-148, which is claimed to be a more specific anti-serotonin agent than dibenamine.
The demonstration that the hypersensitive response could not be blocked by appropriate drugs and that mast cells are not damaged in the inflamed tissues strongly suggested that neither histamine nor serotonin played an important role in the mediation of the reaction. However, to obtain additional evidence, the secondary hypersensitive response was compared in sensitized rats and in sensitized rats "depleted" of mast cells. In addition the response was measured TzxT-F1o. 5. Edema produced by pertussis vaccine 1:5 in sensitized rats and sensitized rats treated with 48/80 or x-irradiation. Edema produced by histamine (200/~g./ml,) and 48/80 (2.0/zg./ml.) in sensitized and non-sensitized rats, and in sensitized rats treated with 48/80 or x-irradiation. Differences between mean increase in tissue water greater than 3.03 per cent are significant with a P value <0.01 when comparing responses based on the same controls. in x-irradiated rats to determine whether this form of injury depressed the pertussis-hypersensitive inflammation in the skin as it may in delayed or tuberculin type hypersensitivity (9).
Thirty six rats were sensitized by the injection of 0.2 ml. of whole pertussis vaccine in the abdominal skin. The sensitized rats were divided into three groups: Group I contained 18 controls, group II consisted of 9 rats treated with 48/80, and group III consisted of 9 rats which were x-irradiated. Group IV contained 24 non-sensitized, non-treated controls. Each rat in group II received a total of 3 rag. of 48/80 given intraperitoneally in increasing doses twice dally from days 6 to 11. Each rat in group III received 500 r total body irradiation on the 9th day. * On the 12th day the right or left paws of 12 rats in groups I and IV and 6 rats in groups II and III were challenged with pertussis vaccine 1:5. Twenty-two hours later uninjected paws of rats in groups I, II, and III were challenged with either histamine (200 #g./ml.) or 48/80 (2 #g./ml.). The uninjected paws of group IV were challenged with histamine (200 #g./ml.) 48/80 (2 #g./ml.) or saline. In group I pertussis vaccine, histamine and 48/80 were each tested in 12 different rats; in groups II and III they were each tested in 6 different rats; in group IV these agents and saline were each tested in 12 different rats. Twenty four hours after challenge with pertussis vaccine 1:5 and 2 hours after challenge with histamine, 48/80 or saline, paw skins were obtained for water determinations.
The results are recorded in Text- fig. 5 . The edema produced by pertussis vaccine in groups I, II, and III is recorded as the increase in tissue water above that found for pertussis vaccine in the paw skins of non-sensitized rats in group IV. The edema produced by histamine and 48/80 is recorded as the increase in tissue water above that found for saline in group IV. The results show again that sensitized rats do not respond to histamine or 48/80 with more edema than non-sensitized controls. Rats treated with 48/80 have a reduced response to 48/80 but not to histamine or pertussis vaccine. In contrast the irradiated rats respond normally to 48/80 and histamine but show a significant reduction in response to pertussis vaccine. With our methods of measurement we failed to demonstrate that tissue histamine and serotonin or an altered reactivity to these agents played an important role in the inflammation of the hypersensitive response to pertussis vaccine. fig. 5 can be applied only to groups using the same controls.
Statistical

DISCUSSION
The experiments demonstrate that rats treated with pertussis vaccine develop severe cutaneous hypersensitivity to pertussis vaccine and to at least some particulate or soluble antigens mixed with pertussis vaccine. Tuberculous rats or rats injected with large doses of killed tubercle bacilli show little or no cutaneous hypersensitivity to tuberculin (10, 11) . It is of interest that tuberculin injected into the foot-pad of C-57 black mice infected with tubercle bacilli produced painful reddened feet swollen to about twice normal thickness; the reactions reached maximum severity at about 24 hours (12) . Though the cutaneous hypersensitive response to pertussis is similar in several respects to the delayed or tuberculin type of hypersensitivity in other species, we do not believe it is desirable to attach a label to the reaction to pertnssis vaccine in the rat at this time.
There is no question that treatment of some strains of mice and rats with pertussis vaccine increases the host's sensitivity to histamine given intravenously or intraperitoneally, to serotonin given by the same routes, and to various toxins and stresses. These effects have been discussed by Pittman (1) and more recently by Munoz et al. (2) . Pertussis-treated rats following anaphylactic shock show degranulation of their mast cells and increased plasma histamine; nevertheless, the role of histamine in producing anaphylactic shock in the pertnssis-treated rat is questioned (13) . Similar doubts were expressed by Malkiel in earlier studies (4) . In the present studies neither histamine nor serotonin has been implicated in the mediation of the cutaneous hypersensitive response. Since neither histamine nor serotonin produces more cutaneous edema in sensitized rats than in non-sensitized rats, it would appear that it is not altered reactivity to these agents which accounts for the hypersensitive reaction.
Some investigators have found that pertussis vaccine acts as an adjuvant; in mice circulating antibody titers were 1 to 3 double dilutions higher for an antigen when it is mixed with pertussis vaccine (14, 15) . The adjuvant action of pertussis vaccine in enhancing circulating antibody titers has not been implicated as important in increasing either the host's resistance to infection (14) or enhancing gross anaphylaxis (5, 15) . Antibody is necessary for gross anaphylaxis, but studies on passive anaphylaxis in pertussis-treated and control mice clearly indicate that treatment with pertnssis vaccine produces an increased reactivity or sensitivity to antigen-antibody complexes separate from any action it may have on antibody formation (2). In our experiments pertussis vaccine did not enhance measured circulating antibodies to typhoid vaccine; we could not passively transfer the cutaneous hypersensitive response with serum. Furthermore, rats injected with pertussis and typhoid vaccine in separate depots did not show cutaneous hypersensitivity to typhoid vaccine. This would suggest that passive Cutaneous hypersensitivity to another antigen could not be produced in pertussis-treated rats. Thus, our studies do not suggest how pertussis vaccine profoundly alters the rat's response to antigens. Do laboratory investigations using pertnssis vaccine in rats and mice have any bearing on the study of human pathology? Others have suggested that some cases of limb paralysis, encephalopathy, or fatal anaphylaxis following pertnssis vaccination may occur because pertussis vaccine has activity in man similar to that in rats and mice (16, 17) . At present pertnssis vaccine is incorporated with two or three other antigens for human immunizations. It is assumed that pertussis vaccine either has no effect on, or it enhances the immunogenicity of, the other antigens. Extensive clinical experience with triple vaccines indicates that no adverse effects occur in the vast majority of immunized individuals. But possibly clinical studies would not detect whether some individuals, following infection or immunization with Hemophilus pertussis, develop sensitivity to an antigen not "mixed" with the vaccine. It would seem to be of considerable theoretical and practical importance to find out if this does occur. Obviously, the human being cannot be tested by systemic shocking with intravenous histamine or antigens. Our studies with the rat indicate that measurement of circulating antibody or measurement of cutaneous edema produced by histamine will not demonstrate altered reactivity of the host to pertussis organisms or to another antigen the host is exposed to at the time of immunization. The present studies suggest a feasible approach to the clinical study of this problem in man. By using skin test techniques in properly designed clinical studies in selected individuals it should be possible to determine whether Hemophilus pertussis organisms are a naturally occurring "adjuvant" for man.
SUMMARY
Itemophilus pertussis vaccine injected into normal rat skin produced local edema lasting several days. Four to 6 days later the injected site became severely inflamed. When uninjected skin was challenged 5 to 28 days after the initial injection, severe inflammation developed at the site of challenge within 12 to 24 hours. This secondary hypersensitive response was elicited by a dose of vaccine which produced little or no initial or delayed inflammation in a normal rat. Specific cutaneous hypersensitivity to a particulate antigen (i.e. typhoid vaccine) or a soluble antigen (human or rabbit gamma globulin) developed when rats were injected with a mixture of the antigen and pertussis vaccine. Pertussis vaccine mixed with typhoid vaccine did not enhance circulating agglutinin formation to typhoid vaccine. Cutaneous hypersensitivity to pertussis vaccine was passively transferred to normal rats by lymph node cells but not with serum from hypersensitive rats. Sensitization with pertussis vaccine did not enhance the edema-producing activity of histamine, serotonin, or 48/80 given subcutaneously. Mast cells in areas of hypersensitive inflam-mation were not damaged appreciably. The hypersensitive inflammation was not inhibited by treatment with anti-serotonin and antihistaminic drugs. Hypersensitive rats "depleted of mast cells" responded to challenge with pertussis vaccine with severe inflammation though their response to 48/80 was depressed. Hypersensitive rats treated with x-irradiation showed decreased hypersensitive inflammation though they responded normally to 48/80 and histamine.
These studies failed to demonstrate a role for circulating antibody in the cutaneous hypersensitive inflammation produced in the rat by pertussis vaccine. Furthermore, the findings indicated that the cutaneous hypersensitive inflammation is not mediated by tissue serotonin and/or histamine. 
